Black Rock Inc. Bausch Health Companies Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Black Rock Inc. holds 218,000 shares of BHC stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,000

Previous 213,485 2.11%

Holding current value

$1.48 Million

Previous $1.71 Million 35.05%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.77 - $10.61 $35,081 - $47,904	4,515 Added 2.11%	218,000 $2.31 Million
Q4 2023 Feb 13, 2024	SELL	$6.53 - $8.23 $145,285 - $183,109	-22,249 Reduced 9.44%	213,485 $1.71 Million
Q3 2023 Nov 13, 2023	SELL	$7.69 - $9.71 $103,745 - $130,997	-13,491 Reduced 5.41%	235,734 $1.94 Million
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $614,539 - $945,445	-107,437 Reduced 30.12%	249,225 $1.99 Million
Q1 2023 May 12, 2023	SELL	$6.28 - $9.85 $168,969 - $265,024	-26,906 Reduced 7.01%	356,662 $2.89 Million

Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $201,798 - $262,768	-33,136 Reduced 7.95%	383,568 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $822,297 - $1.65 Million	179,541 Added 75.7%	416,704 $2.87 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $382,115 - $1.28 Million	54,124 Added 29.57%	237,163 $1.98 Million
Q1 2022 May 12, 2022	BUY	$21.6 - $27.79 $322,012 - $414,293	14,908 Added 8.87%	183,039 $4.18 Million
Q4 2021 Feb 10, 2022	BUY	$23.0 - $29.01 $165,439 - $208,668	7,193 Added 4.47%	168,131 $4.64 Million
Q3 2021 Nov 09, 2021	BUY	$25.04 - $30.06 $20,733 - $24,889	828 Added 0.52%	160,938 $4.48 Million
Q2 2021 Aug 11, 2021	BUY	$27.43 - $32.7 $4.39 Million - $5.24 Million	160,110 New	160,110 $4.7 Million

Others Institutions Holding BHC

# of Institutions

281

Shares Held

278M

Call Options Held

21.5M

Put Options Held

21.8M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.46B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account